Drug or treatment

Adalimumab clinical trials

• 15Clinical trials
• 11Countries

Newest trials

All recruiting trials (15)

• Add-on anti-inflammatory therapy for adults with depression and high inflammation

  This study tests whether adalimumab, given with your regular antidepressant Lexapro, can improve depressive symptoms in adults with major depressive disorder and high inflammation.

  Recruiting Phase 2 University of Pennsylvania · Philadelphia, Pennsylvania · NCT07845604

• Colonic delivery of two antibodies to see if they reach the bloodstream in healthy people

  This early study tests whether guselkumab and adalimumab given directly into the colon can enter the body in healthy adults.

  Recruiting Phase 1 Surmount Services, Inc. · Maroochydore, Queensland · NCT07788807

• Tabellvi for moderate to severe Crohn's disease in Chinese adults

  This real-world, single-arm study tests Tabellvi® (adalimumab) in Chinese adults with moderate to severe Crohn's disease to see how often side effects occur and whether many patients reach remission by week 26.

  Recruiting Phase 4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Fuyang, Anhui and 6 other locations · NCT07663526

• Adalimumab treatment for adults with non-infectious uveitis

  This trial tests whether TyboWe Adalimumab can help adults with non-infectious uveitis who are already on steroids.

  Recruiting Phase 4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tianjin, Tianjin Municipality · NCT07663331

• Adebrelimab with neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma

  This study tests whether giving adebrelimab with paclitaxel, carboplatin, and short-course radiotherapy before surgery helps ESCC patients.

  Recruiting Phase 2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07595770

• Adalimumab in Children with Crohn’s Disease (Pediatric 6–17)

  This study tests Taibowei Adalimumab injections in children aged 6 to 17 who have moderately to severely active Crohn’s disease to see how safe it is over 12, 26, and 52 weeks.

  Recruiting Phase 4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Guangzhou, Guangdong · NCT07564505

• Low-dose ATG followed by adalimumab or verapamil for people with recent-onset type 1 diabetes

  This trial will test whether a short course of low-dose anti-thymocyte globulin (ATG) followed by either adalimumab or verapamil can help preserve insulin production in people aged 9 to under 21 with recent-onset type 1 diabetes.

  Recruiting at 10 sites Phase 1/2 City of Hope Medical Center · Los Angeles, California and 10 other locations · NCT07061574

• Comparing Vedolizumab and Adalimumab for Crohn's Disease Treatment

  This study is testing whether switching to Vedolizumab or increasing the dose of Adalimumab works better for people with Crohn's disease who aren't responding to their current Adalimumab treatment.

  Recruiting at 12 sites Phase 4 Centre Hospitalier Universitaire de Saint Etienne · Le Kremlin-Bicêtre, PARIS and 11 other locations · NCT06180382

• Assessing the safety and effectiveness of risankizumab and adalimumab in children with juvenile psoriatic arthritis

  This study is testing a new medication called risankizumab to see if it works better and is safer than the standard treatment adalimumab for children with juvenile psoriatic arthritis.

  Recruiting at 34 sites Phase 3 AbbVie · Little Rock, Arkansas and 33 other locations · NCT06100744

• Using Adalimumab to treat early inflammatory arthritis caused by immune checkpoint inhibitors

  This study is testing if adalimumab can help people with early inflammatory arthritis caused by cancer treatments to feel better and rely less on steroids.

  Recruiting Phase 2 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06037811

• Comparing Azathioprine and Methotrexate with Adalimumab for Crohn's Disease

  This study is testing whether adding azathioprine or methotrexate to adalimumab helps people with Crohn's disease who haven't improved with other treatments.

  Recruiting Phase 3 Centre Hospitalier Universitaire, Amiens · Amiens · NCT05040464

• Evaluating treatments for severe Takayasu arteritis

  This study tests whether tocilizumab or adalimumab is more effective for people with severe Takayasu arteritis to help tailor treatments based on their specific needs.

  Recruiting Phase 4 Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT04300686

• Comparing standard care with targeted treatment and monitoring for ulcerative colitis patients starting adalimumab

  This study is testing if a new approach that includes extra monitoring and education can help adults with moderate to severe ulcerative colitis feel better when they start treatment with adalimumab, compared to standard care.

  Recruiting at 16 sites Phase 4 Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Cholet, Maine Et Loire and 23 other locations · NCT04183608

• Fluorescence imaging with labeled adalimumab to map inflammation in IBD and rheumatoid arthritis

  This trial will test whether a fluorescent version of adalimumab can highlight inflamed bowel tissue or hand joints in adults with active IBD or rheumatoid arthritis.

  Recruiting Phase 2 University Medical Center Groningen · Groningen, Provincie Groningen · NCT03938701

• Using Enstilar with Enbrel or Humira for treating plaque psoriasis

  This study is testing if using a foam treatment called Enstilar along with Enbrel or Humira can help people with chronic plaque psoriasis improve their skin condition.

  Recruiting Phase 4 Psoriasis Treatment Center of Central New Jersey · East Windsor, New Jersey · NCT03827876

Quick answers

How many clinical trials of Adalimumab are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in China (5 trials), United States (4 trials), France (4 trials), Australia (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 7, Phase 2: 4, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →